Yeon Kim

WORK HISTORY

EDUCATION

ABOUT YEON KIM

Boston-based, Korea-born, and R&D-grounded — I bridge innovation across continents and functions, operating at the intersection of science, strategy, and scale. A results-driven, director-level professional with over a decade in the life sciences industry and 9+ years at LG Chem Life Sciences, I’ve played a key role in driving our global biopharma expansion — from early-stage scouting, R&D portfolio valuation/management, business management and post-M&A integration.I’ve contributed to multiple task forces across LG Group, LG Chem, and LG Chem Life Sciences, committed to shaping long-term strategies spanning pipeline prioritization, therapeutic focus, and global competitiveness.For the recent years, since relocating to Boston in 2022, I’ve led initiatives that shaped our U.S. footprint — including the acquisition and strategic integration of AVEO Oncology.Driven by curiosity and genuine enthusiasm for innovation, I thrive in complex, cross-functional environments. Whether it’s unlocking value through external innovation, aligning global teams behind a shared vision, or advising on growth strategy, I bring deep domain expertise, strategic agility, and a forward-looking mindset — always open to collaborating with Global innovators, visionary IBs, PEs, VCs, and consulting partners at the intersection of healthcare and business transformation.